Advanced search
Publication Cover
Renal Failure Volume 39, 2017 - Issue 1
Submit an article Journal homepage
2,541
Views
7
CrossRef citations to date
0
Altmetric
Clinical Study

Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety

Xiaojuan YuRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Lin RuanRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China; ;Renal Division, Department of Medicine, First Municipal Hospital, Shijiazhuang, Hebei province, P.R. China
,
Zhen QuRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Zhao CuiRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Yimiao ZhangRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Xin WangRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Liqiang MengRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Xiaojing LiuRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Fang WangRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Ying ZhangRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China;
,
Gang LiuRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China; Correspondence[email protected]
&
Li YangRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China; ;Institute of Nephrology, Peking University, Beijing, P.R. China; ;Key laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; ;Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China; Correspondence[email protected]
 show all
Pages 688-697 | Received 23 Oct 2016, Accepted 23 Apr 2017, Published online: 08 Sep 2017

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Honghong Zou, Fang Jiang & Gaosi Xu. (2019) Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy. Renal Failure 41:1, pages 673-681.
Read now

Articles from other publishers (6)

Yajuan Duan, Yu Bai, Weikang Guo, Liyan Wang, Wendi Dai, Wang Guo, Hongdong Huang, Wenhu Liu & Zongli Diao. (2023) Multitarget therapy with a corticosteroid, cyclosporine and mycophenolate mofetil for idiopathic membranous nephropathy: a prospective randomized controlled trial. Nephrology Dialysis Transplantation.
Crossref
Meng-Ru Hua, Yan-Long Zhao, Jun-Zheng Yang, Liang Zou, Ying-Yong Zhao & Xia Li. (2023) Membranous nephropathy: Mechanistic insights and therapeutic perspectives. International Immunopharmacology 120, pages 110317.
Crossref
Kang Li, Yanqiu Yu, Yuan Gao & Junjie Gao. (2022) Comparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy. Medicine 101:8, pages e28891.
Crossref
Hasan H. Yeter, Ipek Isik Gonul, Esra Eraslan, Ceren Karacalik, Betul Ogut & Galip Guz. (2021) Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy. Clinical and Experimental Nephrology 25:5, pages 488-500.
Crossref
Zhiyong Xie, Zhilian Li, Wei Dong, Yuanhan Chen, Ruizhao Li, Yanhua Wu, Huaban Liang, Zhiming Ye, Shuangxin Liu, Wei Shi & Xinling Liang. (2020) The impact of coexisting diabetes mellitus on clinical outcomes in patients with idiopathic membranous nephropathy: a retrospective observational study. BMC Nephrology 21:1.
Crossref
Agnieszka Pozdzik, Isabelle Brochériou, Cristina David, Fahd Touzani, Jean Michel Goujon & Karl Martin Wissing. (2018) Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management. BioMed Research International 2018, pages 1-19.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.